Epilogue
Epilogue
The End of an Error?
This final chapter brings us up to date with the current state of affairs in gene patenting. It discusses the recent US Supreme Court’s decision on the breast cancer patents held by Myriad Genetics. It also discusses the recent move by the FDA to prohibit personal genomics companies from offering their clients medical information based on their genetic sequence. Finally, it considers the role of history of science in current policy issues.
Keywords: breast cancer gene patents, race and genomics, Myriad Genetics, gene patents: Europe vs. US, American Civil Liberties Union, personal genomics companies, public policy
MIT Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.